1. Home
  2. AGIO vs UNFI Comparison

AGIO vs UNFI Comparison

Compare AGIO & UNFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • UNFI
  • Stock Information
  • Founded
  • AGIO 2007
  • UNFI 1976
  • Country
  • AGIO United States
  • UNFI United States
  • Employees
  • AGIO N/A
  • UNFI N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • UNFI Food Distributors
  • Sector
  • AGIO Health Care
  • UNFI Consumer Discretionary
  • Exchange
  • AGIO Nasdaq
  • UNFI Nasdaq
  • Market Cap
  • AGIO 1.4B
  • UNFI 1.6B
  • IPO Year
  • AGIO 2013
  • UNFI 1996
  • Fundamental
  • Price
  • AGIO $38.80
  • UNFI $27.42
  • Analyst Decision
  • AGIO Buy
  • UNFI Hold
  • Analyst Count
  • AGIO 6
  • UNFI 8
  • Target Price
  • AGIO $57.40
  • UNFI $27.00
  • AVG Volume (30 Days)
  • AGIO 976.6K
  • UNFI 818.7K
  • Earning Date
  • AGIO 07-31-2025
  • UNFI 09-30-2025
  • Dividend Yield
  • AGIO N/A
  • UNFI N/A
  • EPS Growth
  • AGIO N/A
  • UNFI N/A
  • EPS
  • AGIO 11.13
  • UNFI N/A
  • Revenue
  • AGIO $40,875,000.00
  • UNFI $32,243,000,000.00
  • Revenue This Year
  • AGIO $18.94
  • UNFI $4.46
  • Revenue Next Year
  • AGIO $201.70
  • UNFI $1.25
  • P/E Ratio
  • AGIO $3.49
  • UNFI N/A
  • Revenue Growth
  • AGIO 30.57
  • UNFI 6.62
  • 52 Week Low
  • AGIO $23.42
  • UNFI $13.18
  • 52 Week High
  • AGIO $62.58
  • UNFI $34.76
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 58.69
  • UNFI 55.89
  • Support Level
  • AGIO $34.71
  • UNFI $26.44
  • Resistance Level
  • AGIO $37.73
  • UNFI $27.39
  • Average True Range (ATR)
  • AGIO 1.50
  • UNFI 0.97
  • MACD
  • AGIO 0.15
  • UNFI -0.02
  • Stochastic Oscillator
  • AGIO 82.21
  • UNFI 86.69

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About UNFI United Natural Foods Inc.

United Natural Foods Inc is a wholesale distributor of natural, organic and specialty foods and nonfood products across North America. The company's products consist of national, regional and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's operations are comprised of principal divisions: the wholesale division; the retail division; and other.

Share on Social Networks: